LLY240726C740000
- 217.02
- 0.000.00%
Eli Lilly and Co Newsroom
Election Watch: Will Conservatives and Liberals Move the Meter With Their Stock Picks?
Eli Lilly, Novo Are Weight-Loss Winners. Rivals Won't Be an Issue for Years: Analyst. -- Barrons.com
Express News | Novo's Weight-Loss Drug Wegovy Receives UK Nod For Heart Disease
Market Whales and Their Recent Bets on LLY Options
Time for Healthcare ETFs?
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
The S&P 500 Typically Outperforms in July, Underperforms August-October - RBC Capital Markets
Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
The trend of weight loss drug sector in US stock market is diverging. Novo Nordisk (NVO.US) and Eli Lilly and Co (LLY.US) face challenges to their duopoly.
As more and more pharmaceutical companies enter the lucrative weight loss drug market to get a share of the pie, the increasing competition is making investors worried about the duopoly position of Novo Nordisk and Eli Lilly and Co in this market.
Up to 20% weight loss! Eli Lilly and Co's Theralogix (Tesofensine) approved in China, stronger effect than Sibutramine?
Is the competition intensifying?
Kamala Harris' Potential Impact on Health Care Stocks
The Race to Develop the 'Holy Grail' of Weight-loss Drugs
Here Are Big Pharma's Leading Blockbuster Makers
Eli Lilly (NYSE:LLY) Seems To Use Debt Quite Sensibly
US stocks closed with all three major indices falling, with the S&P Nasdaq index seeing its largest weekly decline in three months. Technology stocks weakened, with Tesla down more than 4%, Nvidia down more than 2%, and CrowdStrike down more than 11%.
Investors accelerated their escape from technology stocks, with stocks and bonds in Europe and the United States being hit hard for two days. This week, the S&P 500 and Nasdaq fell by about 2% and 3.7%, respectively. The Nasdaq stopped its six-week continuous rise, while the Dow and small-cap indices rose by 0.7% and 1.7%, respectively. Chip stocks fell more than 3% on Friday and nearly 9% for the week. Nvidia also fell more than 8.7% for the past three months, making it the worst performer. The "seven sisters of technology" all fell for the week, and cybersecurity leader Crowdstrike, which triggered a global technology outage, fell 11% on Friday, the worst in nearly two years. The VIX panic index rose more than 32% for the week.
Express News | Benzinga Market Summary: Microsoft And Airlines Outages Linked To Crowdstrike, Crowdstrike Opens Down Over 13%, Eli Lilly Rises After Zepbound Chinese Approval
Express News | Eli Lilly Shares Are Trading Higher After Zepbound Received China Approval
Today's Analyst Rating | Apple Price Target Raised to $260 by Melius Research, CFRA Upgrades Microsoft to Buy